Mark S. Sulkowski, MD

Mark S. Sulkowski, MD

Johns Hopkins University

H-index: 102

North America-United States

About Mark S. Sulkowski, MD

Mark S. Sulkowski, MD, With an exceptional h-index of 102 and a recent h-index of 51 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Viral Hepatitis, HCV, HBV, Co-infection with HIV.

His recent articles reflect a diverse array of research interests and contributions to the field:

Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses

Updated epidemiology of steatotic liver disease in people with HIV in the United States—Authors' reply

Changes in inflammatory cytokines after chronic hepatitis C treatment among people living with HIV

Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States

Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected …

Hepatitis C and cigarette smoking behavior: Themes from focus groups

The effects of food insecurity on hepatic steatosis and fibrosis in people with HIV

Loneliness and fearfulness are associated with non-fatal drug overdose among people who inject drugs

Mark S. Sulkowski, MD Information

University

Position

Professor of Medicine; School of Medicine

Citations(all)

62231

Citations(since 2020)

14282

Cited By

64472

hIndex(all)

102

hIndex(since 2020)

51

i10Index(all)

402

i10Index(since 2020)

187

Email

University Profile Page

Johns Hopkins University

Google Scholar

View Google Scholar Profile

Mark S. Sulkowski, MD Skills & Research Interests

Viral Hepatitis

HCV

HBV

Co-infection with HIV

Top articles of Mark S. Sulkowski, MD

Title

Journal

Author(s)

Publication Date

Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses

JHEP reports

Man-Fung Yuen

Scott Fung

Xiaoli Ma

Tuan T Nguyen

Tarek Hassanein

...

2024/1/18

Updated epidemiology of steatotic liver disease in people with HIV in the United States—Authors' reply

Richie Manikat

Seung Up Kim

Aijaz Ahmed

Donghee Kim

2024/3

Changes in inflammatory cytokines after chronic hepatitis C treatment among people living with HIV

Open Forum Infectious Diseases

Hamidreza Karimi-Sari

Damani A Piggott

Eileen P Scully

Kathleen Ward

Catherine G Sutcliffe

...

2024/1

Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States

Alimentary Pharmacology & Therapeutics

Samer Gawrieh

Eduardo Vilar‐Gomez

Tinsay A Woreta

Jordan E Lake

Laura A Wilson

...

2024/3

Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected …

American Journal of Transplantation

Wesam Aleyadeh

Elizabeth C Verna

Hany Elbeshbeshy

Mark S Sulkowski

Coleman Smith

...

2024/3/1

Hepatitis C and cigarette smoking behavior: Themes from focus groups

Nicotine and Tobacco Research

Julia F Cohen

Kathleen M Ward

Jennifer Gittleman

Esther Perez

Tyler Pia

...

2024/2/29

The effects of food insecurity on hepatic steatosis and fibrosis in people with HIV

Clinical Gastroenterology and Hepatology

Ani Kardashian

Audrey Lloyd

Eduardo Vilar-Gomez

Susanna Naggie

Mark S Sulkowski

...

2024/4/5

Loneliness and fearfulness are associated with non-fatal drug overdose among people who inject drugs

Plos one

Oluwaseun Falade-Nwulia

Kathleen Ward

Karla D Wagner

Hamidreza Karimi-Sari

Jeffrey Hsu

...

2024/2/21

Hepatitis C Treatment in People With HIV: Potential to Eliminate Disease and Disparity

The Journal of Infectious Diseases

Oluwaseun Falade-Nwulia

Catherine R Lesko

Anthony T Fojo

Jeanne C Keruly

Richard D Moore

...

2024/3/15

Is neighborhood deprivation index a risk factor for Staphylococcus aureus infections?

American Journal of Infection Control

Geeta Sood

Geoff Dougherty

John Martin

Edward Beranek

B Mark Landrum

...

2023/12/1

Long-term Follow-up of Hepatitis C Patients Who Achieved Sustained Virologic Response in the Pragmatic PRIORITIZE Study

Clinical Gastroenterology and Hepatology

Anna S Lok

Juhi Moon

Kenneth E Sherman

Mandana Khalili

Dawn Fishbein

...

2023/2/1

Hepatitis D virus infection: Progress on the path toward disease control and cure

Mark S Sulkowski

2023/4

Perspectives on Adherence From the ACTG 5360 MINMON Trial: A Minimum Monitoring Approach With 12 Weeks of Sofosbuvir/Velpatasvir in Chronic Hepatitis C Treatment

Clinical Infectious Diseases

Leonard A Sowah

Laura Smeaton

Irena Brates

Debika Bhattacharya

Benjamin Linas

...

2023/6/1

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos (t) ide analogues for the treatment of chronic …

The Lancet Gastroenterology & Hepatology

Man-Fung Yuen

Tarik Asselah

Ira M Jacobson

Maurizia Rossana Brunetto

Harry LA Janssen

...

2023/9/1

Implementing a peer-supported, integrated strategy for substance use disorder care in an outpatient infectious disease clinic is associated with improved patient outcomes

International Journal of Drug Policy

Oluwaseun Falade-Nwulia

Tracy Agee

Sharon M Kelly

Ju Nyeong Park

Sheree Schwartz

...

2023/11/1

Effect of fluvoxamine vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial

JAMA

Matthew W McCarthy

Susanna Naggie

David R Boulware

Christopher J Lindsell

Thomas G Stewart

...

2023/1/24

Effect of higher-dose ivermectin for 6 days vs placebo on time to sustained recovery in outpatients with COVID-19: a randomized clinical trial

JAMA

Susanna Naggie

David R Boulware

Christopher J Lindsell

Thomas G Stewart

Alex J Slandzicki

...

2023/3/21

Tu1598 PREVALENCE OF NAFLD AMONG LEAN VERSUS OVERWEIGHT AND OBESE PEOPLE WITH HIV

Gastroenterology

Rohit Loomba

Eduardo Vilar-Gomez

Naga P Chalasani

Samer Gawrieh

Sonya Heath

...

2023/5/1

Controlled human infection model for hepatitis C virus vaccine development: trial design considerations

Clinical Infectious Diseases

Jordan J Feld

Julie Bruneau

Gregory J Dore

Marc G Ghany

Bettina Hansen

...

2023/8/15

Joint statement in support of hepatitis C human challenge studies

The Lancet Gastroenterology & Hepatology

Harvey J Alter

Eleanor Barnes

Mia J Biondi

Andrea L Cox

Jake D Eberts

...

2023/11/1

See List of Professors in Mark S. Sulkowski, MD University(Johns Hopkins University)